[Schnitzler syndrome: A review of literature, the authors' observation, and experience with the interleukin-1 inhibitor canakinumab].

Autor: Salugina SO; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Gorodetsky VR; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Fedorov ES; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Lopatina NE; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Evsikova MD; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2017; Vol. 89 (11), pp. 111-115.